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protein (PICalM) that is associated with the development 
of sas in newfoundlands. Pedigree evaluation best sup-
ported an autosomal dominant pattern of inheritance and 
provided evidence that equivocally affected individuals 
may pass on sas in their progeny. Immunohistochemistry 
demonstrated the presence of PICalM in the canine myo-
cardium and area of the subvalvular ridge. additionally, 
small molecule inhibition of clathrin-mediated endocytosis 
resulted in developmental abnormalities within the outflow 
tract (OFt) of Xenopus laevis embryos. the ability to test 
for presence of this PICalM insertion may impact dog-
breeding decisions and facilitate reduction of sas disease 
prevalence in newfoundland dogs. Understanding the role 
of PICalM in OFt development may aid in future molec-
ular and genetic investigations into other congenital heart 
defects of various species.
Abstract Familial subvalvular aortic stenosis (sas) 
is one of the most common congenital heart defects in 
dogs and is an inherited defect of newfoundlands, golden 
retrievers and human children. although sas is known to 
be inherited, specific genes involved in newfoundlands 
with sas have not been defined. We hypothesized that 
sas in newfoundlands is inherited in an autosomal domi-
nant pattern and caused by a single genetic variant. We 
studied 93 prospectively recruited newfoundland dogs, 
and 180 control dogs of 30 breeds. By providing cardiac 
screening evaluations for newfoundlands we conducted a 
pedigree evaluation, genome-wide association study and 
rna sequence analysis to identify a proposed pattern 
of inheritance and genetic loci associated with the devel-
opment of sas. We identified a three-nucleotide exonic 
insertion in phosphatidylinositol-binding clathrin assembly 
PICalM - Genbank accession KF421154.
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Introduction
subvalvular aortic stenosis (sas) is one of the most 
commonly reported congenital heart defects in dogs 
(Buchanan 1999; tidholm 1997). It is characterized by 
an abnormal ridge or ring of tissue in the left ventricular 
outflow tract (lvOt) that resists ventricular ejection, gen-
erates pressure overload, and increases velocity of blood 
flow into the aorta (Pyle and Patterson 1976; Jones et al. 
1982). the gold standard for diagnosis of sas is the dem-
onstration of a subvalvular ridge or ring on post-mortem 
examination. antemortem diagnosis is conventionally 
established by increased lvOt velocity reported by spec-
tral Doppler echocardiogram studies and is augmented 
by the presence of supportive findings such as presence 
of a visible subvalvular ridge, left ventricular hypertro-
phy, post-stenotic aortic dilation and aortic insufficiency 
(O’Grady et al. 1989).
although dogs with a mild form of the disease may 
have a normal lifespan, severely affected dogs may experi-
ence life-threatening arrhythmias, congestive heart failure, 
endocarditis and sudden death. average lifespan for dogs 
with severe sas in one study was just 19 months (Kienle 
et al. 1994). With medical therapy generally consisting 
of beta-blockade, sas-affected dogs live an average of 
4.5 years. although interventional and surgical techniques 
have been evaluated for treatment of sas, no study has 
shown any long-term benefit to these approaches that 
exceeds traditional medical therapy (Meurs et al. 2005). 
this observation has led to an increased interest in disease 
prevention through a heightened understanding of the dis-
ease etiology.
subvalvular aortic stenosis is known to be an inherited 
defect in newfoundland dogs, golden retrievers and chil-
dren (Pyle and Patterson 1976; Jones et al. 1982; stern 
et al. 2012; Petsas et al. 1998; Wessels et al. 2009). the 
pattern of inheritance in newfoundland dogs was previ-
ously investigated in a single extended family of dogs and 
demonstrated to be either autosomal dominant with incom-
plete penetrance or polygenic in origin (Pyle and Patterson 
1976). to our knowledge, molecular analysis of this dis-
ease in newfoundland dogs has never been reported. the 
objective of this study was to evaluate the familial nature 
of sas in the newfoundland through pedigree analysis and 
genome-wide association.
Materials and methods
this study was conducted under the guidelines of the ani-
mal Care and Use Committees of Ohio state University, 
Washington state University and north Carolina state 
University.
sas-affected and unaffected newfoundland dogs were 
recruited for participation in a study to investigate the 
genetic aspects of sas in this breed. Dogs were evaluated 
by veterinary cardiologists at two veterinary teaching hos-
pitals in the United states of america. Cardiac ausculta-
tion and routine echocardiogram were performed on each 
animal. Pedigree information and a Dna sample were 
collected.
two-dimensional echocardiograph including Doppler 
evaluations were performed by board certified cardiolo-
gists or cardiology residents in training. Maximal aortic 
outflow tract velocity (lvOt Vmax) was obtained from sub-
costal imaging, continuous-wave, spectral Doppler trac-
ings during normal sinus rhythm. the diagnosis of sas 
was made by combined auscultation and echocardiography. 
Guidelines for distinguishing sas-affected dogs from nor-
mal dogs developed by the cardiology diplomates of the 
american College of veterinary Internal Medicine stipulate 
lvOt maximal velocities (Vmax) <1.9 m/s as normal, 1.9–
2.4 m/s as equivocal (unknown if affected or unaffected) 
and >2.4 m/s as sas affected (www.archcertify.org). For 
this study, subvalvular aortic stenosis cases were defined 
by presence of a left-basilar systolic heart murmur and a 
maximal aortic outflow tract velocity exceeding 2.5 m/s. 
Controls were defined by having a maximal aortic outflow 
tract velocity ≤1.8 m/s. Dogs with maximal aortic outflow 
tract velocities ranging from 1.81 to 2.49 were classified as 
equivocal for sas. animals were excluded from the study 
if any other congenital heart disease was observed by rou-
tine two-dimension, m-mode, color and spectral Doppler 
echocardiogram.
Pedigree analysis was performed on an extended fam-
ily of 45 newfoundlands. a pedigree was constructed 
to evaluate the pattern of inheritance. these dogs were 
not utilized in the genotype analysis due to close family 
relationship.
Whole venous blood was obtained in ethylenediamine-
tetraacetic acid (eDta) for each affected and control dog 
identified for genetic analysis. Genomic Dna samples 
were prepared (Meurs et al. 2000). In short, cells were 
osmotically lysed in 2X sucrose-triton (pH 7.6), tris–
nH4Cl buffer (pH 7.2) and nuclei were pelleted by cen-
trifugation (2,000 rpm for 20 min at 25 °C). Pellets were 
resuspended in saline-eDta (pH 8.0) with 20 % sDs 
and proteinase K, and incubated overnight at 56 °C. the 
samples were subjected to phenol:chloroform:isoamyl 
(25:24:1, pH 8) and one chloroform extraction. Finally, the 
Dna was precipitated (95–100 % ethanol and 2 M naCl), 
and resuspended in 100–200 μl of te buffer (10 mM tris, 
1 mM eDta, pH 8).
samples of Dna from 24 cases and 24 control new-
foundlands that were unrelated based upon three generation 
pedigrees were selected for genotyping performed by 
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Geneseek agrigrenomics and veterinary Diagnostics1 
using the CanineHD BeadChip2 to obtain single-nucleotide 
polymorphism (snP) data for >170,000 snPs in the canine 
genome. Dogs classified as equivocal were excluded from 
snP analysis due to uncertainty of disease status.
Genotype quality control, filtering and analysis were 
performed using PlInK3 (Purcell et al. 2007). Genotype 
data was filtered to exclude individuals with >10 % missing 
genotypes and snPs with low genotype success <0.03. 
snPs with a minor allele frequency (MaF) <0.05 were 
excluded from the analysis. Data analysis was performed 
with a simple association approach. a simple association 
genome-wide suggestive criteria was set at P ≤ 5 × 10−5 
(Wellcome trust Case Control Consortium 2007). Odds 
ratios were obtained from the simple association in PlInK 
and standardized by inversion if less than one. Manhattan 
plots were constructed for the association data using r 
software.4
two previously identified newfoundland dogs with sas 
were donated for sample collection post-mortem and the 
regions of subvalvular aortic stenosis and ridge tissue were 
harvested and flash frozen. total rna was routinely 
extracted from the subvalvular ridge utilizing the rneasy 
Fibrous tissue Mini Kit.5 additionally, total rna from six 
other non-newfoundland dogs without subvalvular aortic 
stenosis was utilized for comparison and as a part of the 
ongoing genetic research for other disease processes.
total rna quality was checked by running a sample on 
the Bioanalyzer 2100 using the rna 600 nano assay.6 
samples with a rIn score of 8 or higher were quantified on 
a Qubit 2.0 Fluorometer7 and libraries made using the 
truseq rna sample preparation kit, v28 following the 
manufacturer’s protocol. In short erCC exFold rna 
spike In Mix (see footnote 5) was added to total rna and 
poly-a rna was enriched using poly-oligo-t magnetic 
beads (see footnote 5). the enriched mrna was frag-
mented at 98 °C and primed in the presence of Illumina’s 
elute, Prime, Fragment Mix (see footnote 8). First-strand 
cDna was made from the fragmented mrna by priming 
with random hexamer primers and incubating with reverse 
transcriptase. second-strand cDna was synthesized and 
1
 Geneseek agrigrenomics and veterinary Diagnostics, lincoln, 
nebraska, Usa.
2
 Illumina CanineHD BeadChip, Illumina, san Diego, California, 
Usa.
3
 Plink, shaun Purcell, http://pngu.mgh.harvard.edu/purcell/plink/.
4
 the r project for statistical computing, version 2.15.3, http://www. 
r-project.org.
5
 Qiagen sciences, Germantown, Maryland, Uas.
6
 agilent technologies Inc, santa Clara, California, Usa.
7
 life technologies, Grand Island, new York, Usa.
8
 Illumina, san Diego, California, Usa.
the double-stranded cDna purified using aMPure XP 
magnetic beads.9 the cDna fragments had ends repaired, 
a tails and adapters added, underwent PCr amplification 
and cleaning steps according to Illumina’s truseq protocol 
(see footnote 8).
the truseq libraries were initially assessed for quality 
by sequencing at a low level on Illumina’s Hiseq system 
(see footnote 8). specifically, 24 libraries were multiplexed 
per flowcell lane and a 36 bp run performed according to 
Illumina’s protocol (see footnote 8). the resulting 
sequences were assessed for quality and mapped to the 
CanFam3 genome to confirm insert content. Based on tag 
numbers from the 36 bp sequence run libraries were each 
loaded on one lane of an Illumina (see footnote 8) flowcell 
and 76 bp sequenced from both ends of the inserts. High-
quality sequence reads passing the Illumina purity filter 
(see footnote 8) were utilized for further analysis of vari-
ants after their adapter sequences were clipped using 
FastqMcf.10
reads were aligned to canFam3 genome using topHat 
(v1.3.3).11 all possible PCr duplicate reads were identified 
using Picard MarkDuplicates.12 Multi-sample variant call-
ing was performed using samtools13 and variants were fil-
tered to exclude known snPs from dbsnP version 13114 
(sourced from UCsC genome browser for canFam2, 
mapped to canFam3 using UCsC’s liftOver tool,15 then 
subtracted from the called variants using bedtools).16 vari-
ants were then filtered with a custom Perl17 script requiring 
the non-reference variant to be present in at least one new-
foundland dog sample but not in any of the other non-new-
foundland dog samples. all variants were entered into vari-
ant effect Predictor (veP ensembl v. 70)18 and reported. 
variants identified on the chromosomal regions of interest 
previously identified by GWas were reviewed and reported 
if present in both affected newfoundland dogs.
two additionally affected newfoundland dog Dna 
samples were used for preliminary validation screening of 
identified variants. Primers were designed using Primer3 
and variants were validated by standard PCr amplifications 
carried out using accuPrime GC-rich buffer a (see footnote 
5), 2 unit/μl accuPrime GC-rich Dna polymerase (see 
9
 Beckman Coulter Genomics, Danvers, Massachusetts, Usa.
10
 Fastq MCF, http://code.google.com/p/ea-utils/downloads/list.
11
 tophat v1.3.3, http://tophat.cbcb.umd.edu.
12
 Picard, http://picard.sourceforge.net/command-line-overview.shtml.
13
 samtools, http://samtools.sourceforge.net.
14
 DbsnP v 133, http://www.ncbi.nlm.nih.gov/projects/snP/.
15
 UCsC liftOver, http://genome.ucsc.edu/util.html.
16
 Bedtools, http://code.google.com/p/bedtools/.
17
 Perl, http://www.perl.org.
18
 variant effect Predictor, v.70, http://useast.ensembl.org/info/docs/
variation/vep/index.html
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footnote 5), 20 mM each amplification primer, and approxi-
mately 100 ng of template Dna. samples were denatured 
for 3 min (min) at 95 °C followed by 30 cycles of 95 °C for 
30 s (s), 60 °C for 30 s, 72 °C for 30 s, and finally 72 °C 
for 10 min. the annealing temperature was optimized (55–
60 °C) to accommodate the respective primer.
residual amplification primers and dntPs were 
removed from the PCr product using a single-step enzy-
matic cleanup kit.19 amplicons were then subjected to 
nucleotide sequence determination and analyzed on aBI 
3730Xl sequencer.20 the nucleotide sequences were ini-
tially evaluated for a sequence change between affected 
dogs and the published normal canine sequence, (http://
genome.ucsc.edu/cgi-bin/hgc?hgsid=322959945&c=chr1
8&o=46555041&t=46830526&g=xenorefGene&i
=nM_000218) to see if the variants matched those 
reported by rna sequencing data. variants passing this 
phase of quality control were then investigated in a large 
cohort of dogs to include 26 affected newfoundland dogs, 
23 non-affected newfoundland dogs and 180 control dogs 
of 30 different breeds.
statistical analysis of association was performed using 
Prism.21 a fisher’s exact test was utilized to report associa-
tion within the newfoundland dog study population. effect 
size was determined through calculation of relative risk 
and odds ratio. the sensitivity, specificity and mutation 
penetrance were calculated.
the normal and altered sequences of significantly asso-
ciated variants were evaluated for changes that occur in the 
secondary structure or function with five software pro-
grams that assess the impact of genetic variants in various 
ways. these include, GOrIv22 (http://npsapbil.ibcp.
fr/cgibin/npsa_automat.pl?page=npsa_gor4.html; Combet 
et al. 2000), Provean23 v1.1 (http://provean.jcvi.org/
about.php; Chio et al. 2012), Mutation taster24 (http:// 
www.mutationtaster.org; Flicek et al. 2012), I-tasser25 
server (http://zhanglab.ccmb.med.umich.edu/I-tasser/; 
Zhang 2008) and Protean 3D26 (Dnastar, Madison, WI, 
Usa). GOrIv (see footnote 22) predicts the probability of 
a secondary structure at each amino acid position (Combet 
et al. 2000). Mutation taster (see footnote 24) evaluated 
19
 exosaP-It, affymetrix, santa Clara, Ca, Usa.
20
 applied Biosystems, Foster City, Ca, Usa.
21
 Prism 5, GraphPad software Inc, la Jolla, California, Usa.
22
 GOrIv, http://npsapbil.ibcp.fr/cgibin/npsa_automat.pl?page=npsa_ 
gor4.html; Combet et al. 2000.
23
 Provean v1.1, http://provean.jcvi.org/about.php; Chio et al. (2012).
24
 Mutation taster, http://www.mutationtaster.org; Flicek et al. 
(2012).
25
 I-tasser server, http://zhanglab.ccmb.med.umich.edu/I-tasser/; 
Zhang (2008).
26
 Protean 3D, Dnastar, Madison, WI, Usa.
disease-causing potential of genetic sequence alterations 
(Flicek et al. 2012). Provean (see footnote 23) predicts tol-
erance for mutations and scores them as deleterious or not 
deleterious (Chio et al. 2012). I-tasser (see footnote 24) 
predicts the effect of a given amino acid change on the pro-
tein structure in a three-dimensional model (Zhang 2008). 
Commercial software (Protean 3D)(see footnote 26) was 
used to further analyze the I-tasser (see footnote 25) 
output files.
Protein products from the most highly associated variant, 
a 3 base insertion in PICalM, were further investigated 
through immunohistochemical evaluation. Myocardial sec-
tions of the lvOt from the university pathology reposi-
tory from two sas-affected newfoundland dogs (one het-
erozygous for the PICalM insertion and one homozygous 
for the PICalM insertion) and a normal beagle dog were 
utilized. serial sections were first stained by routine hema-
toxylin and eosin, Masson’s trichrome, and verhoeff-van 
Gieson stains to provide histopathologic classification of 
the sas lesions. PICalM immunohistochemistry was then 
carried out as follows: Paraffin-embedded tissue sections 
were subjected to an antigen retrieval protocol [95 °C for 
20 min in 10 mmol/l citrate buffer (pH 6.0)] followed by 
incubation with anti-PICalM antibody (1:200; ls-B5065, 
lifespan Biosciences Inc). a biotinylated goat anti-rabbit 
IgG was used as the secondary antibody. Detection was 
made by avidin–biotin complex kit (vector laboratories, 
Burlingame, Ca) and 3,3′-diaminobenzidine as the chro-
magen (BioGenex, san ramon, Ca); sections were coun-
terstained with hematoxylin.
the role of PICalM in cardiac morphogenesis was 
investigated through the use of in vivo small molecule inhi-
bition. PICalM functions as a clathrin recruiter to the cell 
membrane and as such changes in clathrin availability are 
a plausible downstream effect of mutations in PICalM 
(Maritzen et al. 2012). therefore, a commercially available, 
cell-permeable clathrin inhibition molecule (PItstOP 2 
ab120687, abcam, Cambridge, Ma, Usa) was applied to 
developing X. laevis embryos to evaluate effects on cardiac 
morphology and determine whether developmental changes 
similar to sas may be observed as a result of inhibition of 
clathrin-mediated endocytosis.
Xenopus laevis embryos were obtained by in vitro fer-
tilization as previously described, de-jellied with 2 % 
cysteine-HCl (pH 7.8–8.1), sorted to eliminate abnormal 
individuals, and cultured in 0.1 × MMr (Marc’s Modified 
ringers; sive et al. 1998) at 15–23 °C (sive et al. 1998). 
staging was according to standard methods (nieuwkoop 
and Faber 1994). stock solutions of Pitstop 2 (abcam 
#ab120687) were prepared in DMsO to a concentration 
of 30 mM, as suggested by product information. Four 
embryos were exposed in each well of a 12-well plate 
starting at stage 27/28 (nieuwkoop and Faber 1994) after 
1143Hum Genet (2014) 133:1139–1148 
1 3
fertilization, at final concentrations of 1 and 5 mM. Control 
embryos were exposed to an equivalent volume of DMsO 
only.
Whole embryos were fixed after cardiogenesis as previ-
ously described (stage 40) for immunofluorescence stain-
ing for 45 min in 4 % paraformaldehyde solution (100 mM 
Hepes pH 7.4, 100 mM naCl, 4 % paraformaldehyde), 
followed by four washes in −20 °C Dent’s fixative (80 % 
methanol/20 % DMsO) solution (Fagotto and Gumbiner 
1994). after overnight storage, the embryos were rinsed 
three times with tris–naCl (100 mM tris–HCl pH 7.3, 
100 mM naCl), then incubated for 1 h in tris–naCl. the 
tris–naCl solution was replaced with sucrose/gelatin 
(15 % sucrose/25 % cold water fish gelatin). after over-
night equilibration, the embryos were embedded and fro-
zen in O.C.t. compound (tissue-tek). ten micron sections 
were cut on a leica CM1850 cryostat and picked up on 
coated slides.
slides were allowed to warm to room temperature, then 
post-fixed in acetone for 1 min before being air dried and 
blocked for 30 min in Blocking Buffer (reed et al. 2009). 
For immunohistochemical staining, slides were incubated 
overnight at 4 °C as described (reed et al. 2009) with 
blocking buffer containing the following primary antibody 
dilutions: Fibrillin (DsHB, JB3, 1:100), β-catenin (sCBt, 
H-102; 1:100). after primary antibody incubation, the 
slides were washed twice in PBt for 5 min. the slides were 
then incubated for 3 h in blocking buffer containing alexa 
488-conjugated goat anti-mouse IgG (Invitrogen, a11029; 
1:2,000) and/or alexa 546-conjugated goat anti-rabbit 
IgG (Invitrogen, a11035; 1:2,000), and washed twice in 
PBt for 5 min each. autofluorescence was quenched in 
eriochrome Black (0.2 % w/v in PBs, 5 min), followed by 
several washes in PBs. slides were mounted in Prolong 
Gold (or Prolong Gold with DaPI), cured overnight in the 
dark, and then sealed with nail polish. Fluorescence was 
visualized on a leica sPeII confocal microscope.
Results
Pedigree analysis
Pedigree analysis was performed on information obtained 
from a family of 45 newfoundlands. nine out of 45 dogs 
(7 females, 2 males) were found to be clearly affected 
with sas and had a median Vmax of 3.5 m/s (2.5–6.0), 12 
(7 females, 5 males) were considered equivocal with high 
suspicion for sas and had a median Vmax of 2.0 m/s (1.9–
2.3) and 24 were unaffected (14 females, 10 males) with a 
median Vmax of 1.7 m/s (1.4–1.8). all equivocal and affected 
dogs within this extended family had a systolic heart mur-
mur and were noted to have color-flow Doppler evidence 
of aortic insufficiency and/or a subvalvular ridge visible 
by 2D echocardiogram of the lvOt. equivocal dogs when 
mated with normal dogs produced clearly affected puppies. 
Within this family, two separate matings of an sas equivo-
cal dog to a normal dog produced severely affected puppies 
with aortic velocities exceeding 5.0 m/s. no unaffected to 
unaffected mating was observed in this family, however, the 
presence of either an affected or equivocal dog within each 
generation supports the previous reports of a possible domi-
nant pattern of inheritance with variable penetrance in new-
foundland dogs with sas (Fig. 1).
Fig. 1  Pedigree representing an extended family of 53 newfound-
lands evaluated for sas and depicted with the following key: circles 
represent females; squares represent males; open symbols are unaf-
fected; blackened symbols are affected; striped symbols are equivo-
cal; a diagonal line through the symbol represents sudden death; and 
symbols containing question marks have unknown phenotypes as 
they were not evaluated as part of this study
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Genome-wide association study
a separate population of 48 newfoundlands that were 
unrelated, at least within three generations, was used for 
the GWas study. the genotyped control dogs (10 males, 
14 females) had a median age of 3.5 years (1–8 years) 
and lvOt Vmax of 1.6 m/s (1.5–1.75). Genotyped cases 
(11 males, 13 females) had a median age of 2.5 years 
(14 weeks–7 years) and lvOt Vmax of 3.83 m/s (2.5–7.5).
after frequency and genotype pruning of individuals 
and snPs, 18 of 24 cases and 20 of 24 controls remained 
and 122,184 out of 173,622 snPs remained for analysis. 
thirteen chromosomal regions met genome-wide sugges-
tive threshold for association with disease phenotype as fol-
lows: chromosomes 3, 5, 7, 9, 10, 12, 15, 20, 21, 24, 27, 
30 and 38 (Fig. 2). Genome inflation factor based upon a 
median Chi-squared test equaled 1.87 indicating a compo-
nent of population stratification such as cryptic relatedness 
between the samples and potentially explaining the multi-
ple chromosomal regions of interest (Yang et al. 2011).
rna sequence analysis
rna sequence analysis revealed a three-nucleotide inser-
tion in exon 16 of canine PICalM at amino acid position 
600 (K599_l600insl). the insertion adds a leucine to the 
amino acid sequence (Fig. 3). validation of this variant was 
performed and found to associate with disease by Fisher’s 
exact test (P < 0.0001). the odds ratio was estimated at 
70.83 (95 % CI 7.8–642) with a relative risk of 14.52 (95 % 
CI 2.14–98.32). sensitivity and specificity for disease 
prediction based upon mutation status were 96 and 74 %, 
respectively. Overall 25 of 26 sas-affected newfoundland 
dogs possessed the insertion mutation (9 homozygous, 16 
heterozygous); 6 of 23 non-affected newfoundland dogs 
possessed the mutation (1 homozygous, 5 heterozygous); 
and none of 180 control dogs of 30 breeds possessed the 
mutation in any form (Fig. 4). Penetrance is thus calculated 
within this study population at 80.6 % in newfoundland 
dogs and at 76 and 90 %, respectively, for heterozygous and 
homozygous genotypes. three additional non-newfound-
land dogs with sas were evaluated and found to possess 
the same PICalM insertion (1 German shepherd Dog, 1 
american staffordshire terrier and 1 golden retriever dog).
Provean (see footnote 23) prediction revealed the K599_
l600insl variant to be deleterious with a Provean score of 
−3.797 (Chio et al. 2012). GorIv (see footnote 22) second-
ary structure analysis of canine PICalM exon 16 mutant 
and normal sequences predicted reduction in the extended 
strand downstream from the insertion and increased ran-
dom coil in the mutant protein product (Combet et al. 
2000).
I-tasser three-dimensional protein modeling identi-
fied visible structural variation that impacts the remainder 
of the protein (see footnote 25) product downstream from 
the insertion mutation (Fig. 5; Zhang 2008). Mutation 
taster (see footnote 23) predicts possible loss of a func-
tion protein region due to the insertion mutation centered 
Fig. 2  Manhattan plot demonstrating association of snP markers with sas in newfoundlands graphed as chromosomal location versus –log10 
of Praw value. the red line represents the threshold of genome-wide suggestive loci
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on a possible loss of breakpoint for translocation to form 
CalM/Mllt10 fusion protein a transcriptional regula-
tion complex with a confidence for accurate predictions at 
0.99/1.0 (Flicek et al. 2012).
Immunohistochemical analysis
all negative control slides revealed absence of background 
staining and appropriate quality control. the subvalvu-
lar ridge region of the heterozygous newfoundland and 
homozygous newfoundland dogs were morphologically 
diverse. all samples contained obvious collagen and fibrous 
connective tissue as identified by Masson’s trichrome stain-
ing. vvG staining revealed small amounts of black elastic 
staining within the ridge and supporting myocardial tissue. 
PICalM antibody positivity was identified in the ridge and 
Fig. 3  Comparative sequencing results showing unaffected newfoundland dogs, homozygous mutant newfoundland dogs, heterozygous mutant 
newfoundland dogs and other unaffected dog breeds as sequencing files with expanded tracings for comparison
Fig. 4  a bar graph represents genotypes of newfoundland dogs 
sequenced for the PICalM insertion associated with sas. Check-
ered regions represent normal newfoundland dogs while blackened 
regions demonstrate sas-affected newfoundland dogs
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the myocardium of all dogs including the myocardium of 
the control beagle, demonstrating its presence in myocar-
dium and lvOt. the appearance of the ridge and its immu-
nohistochemical staining pattern were diverse between the 
two genotypes, however, sample numbers are not sufficient 
to identify differences in protein expression by genotype 
beyond confirmation of PICalM presence in these tissues 
(Fig. 6).
small molecule inhibition of clathrin
small molecule inhibition of clathrin resulted in devel-
opmental abnormalities in stage 40 X. laevis embryos as 
depicted (Fig. 7). Clathrin-inhibited embryos exhibited 
stenotic and shortened cardiac outflow tracts when com-
pared to control embryos. these in vivo pharmacological 
inhibition studies are consistent with a functional role for 
PICalM in outflow tract morphogenesis.
Discussion
subvalvular aortic stenosis is a complex and significant 
congenital heart disease observed in both dogs (Buchanan 
1999; tidholm 1997) and human beings (valeske et al. 
2011). although it is often characterized by the presence 
of an abnormal ridge of tissue in the left ventricular out-
flow tract, the morphology of the lesion can be varied and 
include ring or diffuse tunnel lesions (Pyle and Patterson 
1976; Jones et al. 1982; valeske et al. 2011). the familial 
and molecular basis of the defect in both species is poorly 
understood although a previous description of the pattern 
of inheritance in a canine model in the newfoundland 
dog breed suggested either an autosomal dominant with 
incomplete penetrance or a polygenic mode of inherit-
ance (Pyle and Patterson 1976). the findings reported here 
in this same canine model are most closely suggestive of 
an autosomal dominant mode of inheritance with incom-
plete penetrance. Interestingly, the results are particularly 
consistent with this mode of inheritance if dogs classically 
phenotyped as equivocal due to weak phenotypic findings 
are reclassified as affected. In the family provided here, 
several affected dogs were produced from the mating of an 
unaffected and an equivocal dog. Importantly, although this 
mode of inheritance is plausible, it is equally plausible to 
consider more complex inheritance patterns for this con-
dition. the worsening of sas lesions with advancing age 
makes phenotypic characterization of this disease challeng-
ing in young dogs. the wide variety of lesions associated 
with condition further confounds diagnosis in the antemor-
tem period. Understanding this combination of concerns is 
crucial to pedigree analysis. as such, an intermediate mode 
of inheritance with or without complete penetrance must be 
considered for this disease and cannot be excluded based 
upon these newfoundland dog families.
Molecular analysis identified that a genetic mutation in 
an exonic region of the PICalM gene was strongly asso-
ciated with the development of sas in the dogs evaluated 
here. although a single region of interest was not readily 
identified by genome-wide association study, genome-wide 
suggestive regions were found which highlighted the chro-
mosome harboring the identified mutation in PICalM. 
this underscores a limitation of GWas in a purebred dog 
population where individuals are frequently related and the 
population substructure may be poorly understood.
PICalM is a known mediator of endocytosis at the cel-
lular level and this process is involved in the morphogen-
esis of the heart during embryonic development. PICalM 
is involved in cellular trafficking, endocytosis regula-
tion and clathrin-mediated vesicle formation (Maritzen 
et al. 2012). It is tightly associated with iron homeosta-
sis and cellular proliferation (scotland et al. 2012). these 
Fig. 5  three-dimensional 
protein models of the PICalM 
gene in normal dogs (a) and 
mutant newfoundland dogs (b) 
with the 599K_600linsl muta-
tion. the downstream protein 
conformation is predicted as 
distorted. the blue shaded 
region on each protein model 
corresponds to exon 16 where 
the insertion mutation is loca-
tion in sas-affected newfound-
land dogs
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physiologic roles are strongly tied to embryonic morpho-
genetic events, including those that occur in the neural 
crest and heart (strilic et al. 2010). since PICalM func-
tions as a clathrin recruiter (Maritzen et al. 2012), the role 
of PICalM in cardiac morphogenesis was investigated in 
X. laevis embryos by inhibiting clathrin to demonstrate the 
likely impact of a PICalM mutation. the embryos demon-
strated outflow tract changes when compared to the control 
embryos. aggregation of amyloid substance is one function 
of PICalM and may represent a pathogenic mechanism of 
neural plaque formation and we propose a similar aggre-
gation mechanism as one possibility for generation of the 
subvalvular ridge in sas (D’angelo et al. 2013). While 
the exact functional mechanism for generation of the sub-
valvular ridge in sas is yet to be determined, a role for 
PICalM in cardiac morphogenesis is strongly suggested 
by our experiments with X. laevis embryos in which inhi-
bition of clathrin-mediated endocytosis demonstrated the 
likely impact of a PICalM mutation.
this study represents the first report of mutation associa-
tion for sas in dogs. Molecular analysis identified that a 
genetic mutation in an exonic region of the PICalM gene 
was strongly associated with the development of sas in 
this canine model as well as in three other dogs from dif-
ferent breeds with sas, indicating that the PICalM inser-
tion is not isolated to that one breed and may be important 
Fig. 6  Comparative histopathology of a lvOt subvalvular ridge and 
myocardium from a newfoundland heterozygous for the PICalM 
insertion (1) and a newfoundland homozygous for the PICalM 
insertion (2). light microscopy images at 20× resolution are pre-
sented for routine hematoxylin and eosin (a), Masson’s trichrome 
(b), verhoeff-van Gieson (c) staining for elastic tissue black in color, 
PICalM antibody in lvOt ridge (d) staining PICalM brown and 
PICalM antibody in lv myocardium (e) staining PICalM brown
Fig. 7  Comparative immunohistochemical imaging of a stage 40 
Xenopus laevis control embryo (DMsO) versus a 5 uM treated Pit-
stop embryo. the top row a, b shows the full section while the mid-
dle row c, d and bottom row e, f are successive magnification of the 
squared region to better visualize the outflow tract. the neural tube 
(nt), outflow tract (OFt), and pharyngeal cavity (Ph) are visualized. 
the fluorescent staining represents fibrillin (green), beta-catenin (red) 
and DaPI nuclear stain (blue)
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in other breeds and species as well. Future investigation 
into other breeds with sas and human beings that have an 
inherited form of discrete subaortic stenosis is warranted.
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